OBJECTIVE: To investigate the appearance and elimination of brain-specific S-100 protein in serum during and immediately after cardiopulmonary bypass. DESIGN: Prospective study. PARTICIPANTS: Twenty-nine patients undergoing elective cardiac surgery. INTERVENTIONS: Twenty-seven patients were operated on for coronary artery disease; two patients had valve replacement. Serial measurements of S-100 in arterial blood during and up to 48 hours after cardiopulmonary bypass were made. MEASUREMENTS AND MAIN RESULTS: The perioperative and postoperative course was uneventful in 25 patients, with no clinical signs of neurologic complications. S-100 was not detected before extracorporeal circulation was started. Detectable concentrations (detection limit, 0.2 microgram/L) appeared in serum after 10 minutes of perfusion and reached maximum levels, 2.43 +/- 0.3 micrograms/L, at the end of bypass. The levels then declined with elimination t1/2 of 2.2 hours. Only two patients had detectable concentrations of S-100 48 hours after the end of bypass. In four patients who developed clinical signs of cerebral injury, levels of S-100 were significantly higher at the end of bypass and 24 hours after the end of bypass. CONCLUSIONS: Cardiopulmonary bypass initiates a release of brain-specific S-100 to the systemic circulation. The release and elimination of S-100 seem to follow a reproducible pattern in patients with no signs of cerebral injury. In patients who developed cerebral injury, the concentrations of S-100 in blood were increased, thus suggesting that S-100 may be a usable marker for cerebral injury after extracorporeal circulation.
OBJECTIVE: To investigate the appearance and elimination of brain-specific S-100 protein in serum during and immediately after cardiopulmonary bypass. DESIGN: Prospective study. PARTICIPANTS: Twenty-nine patients undergoing elective cardiac surgery. INTERVENTIONS: Twenty-seven patients were operated on for coronary artery disease; two patients had valve replacement. Serial measurements of S-100 in arterial blood during and up to 48 hours after cardiopulmonary bypass were made. MEASUREMENTS AND MAIN RESULTS: The perioperative and postoperative course was uneventful in 25 patients, with no clinical signs of neurologic complications. S-100 was not detected before extracorporeal circulation was started. Detectable concentrations (detection limit, 0.2 microgram/L) appeared in serum after 10 minutes of perfusion and reached maximum levels, 2.43 +/- 0.3 micrograms/L, at the end of bypass. The levels then declined with elimination t1/2 of 2.2 hours. Only two patients had detectable concentrations of S-100 48 hours after the end of bypass. In four patients who developed clinical signs of cerebral injury, levels of S-100 were significantly higher at the end of bypass and 24 hours after the end of bypass. CONCLUSIONS: Cardiopulmonary bypass initiates a release of brain-specific S-100 to the systemic circulation. The release and elimination of S-100 seem to follow a reproducible pattern in patients with no signs of cerebral injury. In patients who developed cerebral injury, the concentrations of S-100 in blood were increased, thus suggesting that S-100 may be a usable marker for cerebral injury after extracorporeal circulation.
Authors: J W Wirds; A E J Duyn; S D Geraerts; E Preijer; J A A M Van Diemen-Steenvoorde; J H Schagen Van Leeuwen; F J L M Haas; W B M Gerritsen; A De Boer; J A Leusink Journal: Arch Dis Child Fetal Neonatal Ed Date: 2003-01 Impact factor: 5.747
Authors: Andrew Laflam; Brijen Joshi; Kenneth Brady; Gayane Yenokyan; Charles Brown; Allen Everett; Ola Selnes; Edward McFarland; Charles W Hogue Journal: Anesth Analg Date: 2015-01 Impact factor: 5.108
Authors: E S Connolly; C J Winfree; A Rampersad; R Sharma; W J Mack; J Mocco; R A Solomon; G Todd; D O Quest; Y Stern; E J Heyer Journal: Neurosurgery Date: 2001-11 Impact factor: 4.654
Authors: Stefanie Schulte; Leslie W Podlog; J Jordan Hamson-Utley; Frederick G Strathmann; Heiko K Strüder Journal: J Athl Train Date: 2014 Nov-Dec Impact factor: 2.860
Authors: T Rappold; A Laflam; D Hori; C Brown; J Brandt; C D Mintz; F Sieber; A Gottschalk; G Yenokyan; A Everett; C W Hogue Journal: Br J Anaesth Date: 2016-01 Impact factor: 9.166